Adaptimmune Therapeutics Plc (ADAPY)
0.0329
0.00 (0.00%)
USD |
OTCM |
Jun 09, 16:00
Adaptimmune Therapeutics Total Assets (Quarterly) : 130.63M for June 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2025 | 130.63M |
| March 31, 2025 | 158.07M |
| December 31, 2024 | 245.96M |
| September 30, 2024 | 317.44M |
| June 30, 2024 | 321.70M |
| March 31, 2024 | 258.01M |
| December 31, 2023 | 282.62M |
| September 30, 2023 | 296.64M |
| June 30, 2023 | 342.98M |
| March 31, 2023 | 288.08M |
| December 31, 2022 | 328.92M |
| September 30, 2022 | 332.20M |
| June 30, 2022 | 388.27M |
| March 31, 2022 | 419.80M |
| December 31, 2021 | 469.54M |
| September 30, 2021 | 353.53M |
| June 30, 2021 | 389.79M |
| March 31, 2021 | 411.58M |
| December 31, 2020 | 451.14M |
| Date | Value |
|---|---|
| September 30, 2020 | 479.02M |
| June 30, 2020 | 512.20M |
| March 31, 2020 | 285.24M |
| December 31, 2019 | 181.54M |
| September 30, 2019 | 208.25M |
| June 30, 2019 | 239.52M |
| March 31, 2019 | 270.44M |
| December 31, 2018 | 276.74M |
| September 30, 2018 | 309.62M |
| June 30, 2018 | 211.30M |
| March 31, 2018 | 247.07M |
| December 31, 2017 | 281.15M |
| September 30, 2017 | 301.38M |
| June 30, 2017 | 284.28M |
| March 31, 2017 | 265.98M |
| December 31, 2016 | 234.52M |
| September 30, 2016 | 222.64M |
| June 30, 2016 | 239.56M |
| March 31, 2016 | 261.56M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Kiniksa Pharmaceuticals International Plc | 825.28M |
| Autolus Therapeutics Plc | 527.06M |
| Aptorum Group Ltd. | 18.69M |
| Bicycle Therapeutics Plc | 652.40M |
| Barinthus Biotherapeutics Plc | 92.14M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 201.59M |
| Shareholders Equity (Quarterly) | -70.96M |